type
interferon
ifn
famili
antivir
cytokin
produc
earli
respons
viral
infect
rna
intermedi
viral
replic
recogn
cytosol
endosom
pattern
recognit
receptor
prr
rigilik
receptor
rlr
tolllik
receptor
tlr
signal
adaptor
molecul
eg
mav
trif
transcript
factor
eg
induc
type
ifn
express
secret
type
ifn
bind
heterodimer
receptor
ifnar
mediat
pleiotrop
effect
downstream
canon
janu
kinas
jak
signal
transduc
activ
transcript
stat
signal
pathway
result
induct
antivir
ifnstimul
gene
isg
activ
antigenpres
cell
regul
cytokin
chemokin
product
review
although
ifnar
express
nucleat
cell
individu
cell
type
may
respond
differ
signal
type
ifn
evidenc
overlap
yet
distinct
transcript
program
cell
integr
member
mammalian
innat
adapt
immun
respons
mous
express
highli
dendrit
cell
dc
subset
macrophag
popul
select
cell
subset
cell
profession
antigen
present
cell
respond
viral
infect
number
prr
includ
rlr
dc
process
present
antigen
express
costimulatori
molecul
secret
cytokin
chemokin
regul
cell
migrat
leukocyt
recruit
activ
adapt
immun
west
nile
viru
wnv
member
flavivirida
famili
positivestrand
envelop
rna
virus
caus
neuroinvas
diseas
human
vertebr
anim
mosquito
transmit
wnv
skin
cell
keratinocyt
believ
initi
target
infect
infect
dc
migrat
drain
lymph
node
ln
viral
replic
ensu
result
viremia
spread
peripher
organ
viral
replic
skin
ln
induc
local
system
type
ifn
respons
critic
limit
wnv
replic
prevent
dissemin
brain
spinal
cord
inde
subcutan
wnv
infect
ifnar
mice
result
rapidli
fatal
infect
associ
high
viremia
alter
tissu
cellular
tropism
compar
wildtyp
wt
mice
analog
mice
lack
rlr
signal
exhibit
increas
suscept
wnv
infect
mani
tissu
recent
report
also
observ
control
regul
wnv
infect
requir
product
inflammasom
activ
synerg
type
ifn
signal
suppress
wnv
replic
signific
cell
typespecif
respons
ifn
vivo
context
control
viral
pathogenesi
well
understood
prior
experi
wnv
infect
suggest
type
ifn
signal
distinct
tempor
function
develop
adapt
immun
gener
cell
typespecif
condit
delet
ifnar
allow
role
specif
cell
type
analyz
context
infecti
inflammatori
neoplast
diseas
studi
shown
enhanc
suscept
mous
hepat
mhv
noroviru
mnov
infect
anim
condit
ifnar
delet
associ
greater
viral
burden
decreas
surviv
compar
wt
anim
evalu
wnv
pathogenesi
mice
lack
ifnar
express
cell
cre
ifnar
ff
mice
lysm
cre
ifnar
ff
mice
remark
delet
ifnar
either
cell
result
sever
wnv
diseas
essenti
copi
phenotyp
complet
ifnar
mice
thu
domin
antivir
effect
vivo
type
ifn
signal
wnv
occur
myeloid
cell
type
analysi
wnvinfect
mice
reveal
preferenti
infect
ifnar
myeloid
cell
result
syndrom
cytokin
storm
associ
liver
kidney
damag
rapid
death
immunopathogenesi
wnvinfect
ifnar
cre
ifnar
ff
mice
anim
mitig
exogen
administr
block
antibodi
sepsi
syndrom
associ
massiv
altern
pathway
complement
activ
tissu
damag
improv
mice
lack
complement
compon
factor
b
experi
suggest
high
level
viral
replic
wnvinfect
ifnar
myeloid
cell
trigger
uncontrol
product
proinflammatori
cytokin
patholog
complement
induct
activ
togeth
contribut
sepsislik
syndrom
vivo
wnv
preferenti
infect
myeloid
cell
peripher
tissu
neuron
brain
spinal
cord
given
dc
target
wnv
infect
produc
antivir
cytokin
shape
adapt
immun
hypothes
type
ifn
signal
cell
orchestr
protect
wnv
assess
role
type
ifn
receptor
signal
dc
util
cre
ifnar
ff
mice
ifnar
express
markedli
decreas
dc
maintain
hematopoiet
cell
includ
neutrophil
natur
killer
b
cell
data
shown
infect
ifnar
mice
wnv
result
mortal
mean
surviv
time
day
report
previous
unexpectedli
infect
cre
ifnar
ff
mice
result
essenti
phenotyp
fig
differ
mean
surviv
time
compar
ifnar
mice
although
wnvinfect
ifnar
cre
ifnar
ff
mice
rapidli
deterior
clinic
sign
neuroinvas
diseas
includ
limb
paralysi
seizur
ataxia
sustain
tremor
appar
ifnar
cre
ifnar
ff
mice
vulner
wnv
infect
ifnar
ff
litterm
control
cre
ifnar
ff
mice
lack
ifnar
express
b
cell
decreas
express
ifnar
cre
ifnar
ff
cell
confirm
mice
follow
wnv
infect
fig
thu
loss
ifnar
express
cell
result
clinic
phenotyp
wnv
infect
nearli
ident
delet
ifnar
cell
repeat
subset
experi
lysm
cre
ifnar
ff
mice
delet
ifnar
express
monocyt
granulocyt
data
shown
similar
rapid
death
phenotyp
observ
wnv
infect
fig
minim
longer
surviv
time
mean
day
compar
ifnar
cre
ifnar
ff
mice
determin
whether
suscept
phenotyp
cre
ifnar
ff
mice
could
gener
arthropodborn
virus
infect
anim
chikungunya
viru
chikv
unrel
arthritogen
alphaviru
fig
chikv
preferenti
target
myoblast
fibroblast
popul
report
infect
dc
seen
previous
ifnar
mice
infect
chikv
succumb
infect
within
day
contrast
cre
ifnar
ff
lysm
cre
ifnar
ff
ifnar
ff
litterm
control
mice
fail
develop
lethal
chikv
infect
thu
select
delet
ifnar
express
myeloid
cell
make
mice
vulner
virus
even
complet
gene
delet
result
consist
studi
coronaviru
mhv
show
partial
lethal
phenotyp
cre
ifnar
ff
mice
next
assess
whether
loss
ifnar
express
cell
impact
tissu
viral
burden
extent
ifnar
mice
high
titer
ffumg
wnv
detect
spleen
liver
lung
kidney
brain
heart
ifnar
cre
ifnar
ff
mice
hour
post
infect
fig
expect
greater
infect
observ
ifnar
cre
ifnar
ff
mice
compar
ifnar
ff
litterm
control
similar
trend
wnv
infect
observ
serum
ifnar
cre
ifnar
ff
lysm
cre
ifnar
ff
mice
hour
fig
flow
cytometr
analysi
immun
cell
blood
infect
ifnar
mice
reveal
intracellular
wnv
antigen
cell
cell
cell
cell
fig
consist
earlier
report
infect
cre
ifnar
ff
mice
wnv
antigen
detect
percent
cell
percent
cell
coexpress
vari
amount
wnvinfect
ifnar
ff
mice
viral
antigen
cell
blood
near
threshold
detect
hour
infect
thu
loss
ifnar
signal
subset
cell
creat
permiss
intracellular
environ
wnv
replic
necropsi
hour
post
infect
reveal
gross
macroscop
tissu
damag
includ
hemorrhag
infarct
edema
liver
spleen
ln
ifnar
cre
ifnar
ff
mice
evid
wnvinfect
ifnar
ff
mice
data
shown
histolog
analysi
viscer
organ
ifnar
cre
ifnar
ff
mice
show
increas
cellular
infiltr
coagul
necrosi
tissu
destruct
wnv
infect
liver
spleen
drain
ln
compar
ifnar
ff
mice
howev
littl
cellular
infiltr
tissu
destruct
observ
brain
mice
earli
time
point
fig
termin
deoxynucleotidyl
transferas
dutp
nick
end
label
tunel
analysi
confirm
greater
number
dead
cell
liver
spleen
ln
brain
ifnar
cre
ifnar
ff
mice
fig
immunohistochemistri
ihc
perform
determin
whether
phenotyp
correl
cellular
infect
despit
high
titer
ffumg
infecti
viru
liver
homogen
fig
observ
rel
low
level
wnv
antigen
stain
hepat
section
ifnar
cre
ifnar
ff
mice
fig
also
fail
observ
obviou
brain
patholog
mice
hour
correl
pauciti
viral
antigen
tissu
section
comparison
wnv
antigen
stain
appar
drain
ln
spleen
ifnar
cre
ifnar
ff
mice
compar
ifnar
ff
mice
fig
k
combin
flow
cytometri
data
cell
subset
fig
analysi
suggest
enhanc
viral
burden
ifnar
cre
ifnar
ff
mice
attribut
preferenti
infect
ifnar
cell
high
viral
titer
organ
eg
liver
brain
show
littl
wnv
antigen
stain
ihc
might
due
infect
ifnar
cell
retain
blood
vessel
anim
show
deterior
clinic
phenotyp
difficult
perfus
despit
larg
volum
salin
administr
overal
histolog
reveal
high
degre
tissu
injuri
lymphoid
compart
wnvinfect
ifnar
cre
ifnar
ff
mice
reflect
enhanc
infect
cell
lack
ifnar
express
tissu
destruct
organ
howev
appear
commensur
level
viral
antigen
present
tissu
parenchyma
understand
ifnar
cre
ifnar
ff
mice
succumb
rapidli
wnv
infect
analyz
blood
chemistri
hour
wnv
inocul
observ
increas
level
blood
urea
nitrogen
bun
ifnar
cre
ifnar
ff
mice
mgdl
mgdl
respect
versu
mgdl
p
fig
serum
creatinin
mgl
mgl
respect
versu
mgl
p
fig
alanin
aminotransferas
alt
ul
ul
respect
versu
ul
p
fig
aspart
aminotransferas
ast
ul
ul
respect
versu
ul
p
fig
decreas
level
glucos
mgdl
mgdl
respect
versu
mgdl
p
fig
compar
infect
ifnar
ff
mice
elev
serum
bun
creatinin
valu
indic
wnvinfect
ifnar
cre
ifnar
ff
mice
experienc
acut
renal
injuri
elev
liver
enzym
alt
ast
reflect
acut
hepat
injuri
could
due
direct
viral
infect
although
seen
ihc
immunemedi
injuri
ischemia
observ
hypoglycemia
may
secondari
deplet
glycogen
store
impair
gluconeogenesi
increas
peripher
glucos
util
occur
infect
sepsi
similarli
elev
serum
level
ast
alt
decreas
level
glucos
observ
wnvinfect
lysm
cre
ifnar
ff
mice
compat
syndrom
acut
hepat
injuri
fig
understand
basi
organ
damag
ifnar
lysm
cre
ifnar
ff
cre
ifnar
ff
mice
wnv
infect
measur
serum
level
pro
antiinflammatori
cytokin
chemokin
use
bioplex
assay
fig
tabl
hour
infect
detect
differ
cytokin
level
among
ifnar
ff
ifnar
cre
ifnar
ff
mice
howev
one
day
later
observ
increas
level
proinflammatori
cytokin
ifnar
cre
ifnar
ff
mice
compar
ifnar
ff
mice
cytokin
panel
elev
mice
lack
ifnar
express
cell
tabl
examin
cytokin
profil
serum
lysm
cre
ifnar
ff
hour
wnv
infect
also
reveal
increas
measur
cytokin
chemokin
fig
tabl
detect
fold
increas
p
level
individu
proinflammatori
cytokin
wnv
infect
includ
vasoact
eg
inflammasomegener
eg
cytokin
massiv
increas
multipl
proinflammatori
cytokin
wnv
infect
ifnar
lysm
cre
ifnar
ff
mice
coupl
renal
hepat
injuri
low
viral
antigen
stain
tissu
suggest
pictur
sepsi
due
cytokin
storm
comparison
rel
small
increas
six
cytokin
observ
chikv
infect
ifnar
ifnar
ff
mice
fig
tabl
hypothes
myeloid
cell
produc
high
level
proinflammatori
cytokin
respons
extens
viral
replic
rna
pathogenassoci
molecular
pattern
pamp
gener
demonstr
cell
vivo
induc
proinflammatori
cytokin
perform
qrtpcr
analysi
cell
isol
antibodyco
magnet
bead
separ
spleen
ifnar
mice
cell
higher
level
mrna
viral
rna
compar
isol
ifnar
ff
mice
fig
wnvinfect
ifnar
cell
produc
proinflammatori
cytokin
suggest
linkag
uncontrol
viru
replic
cytokin
storm
recent
studi
suggest
context
lpsprime
mav
provid
second
signal
inflammasom
assembl
convers
pro
matur
consist
hypothesi
excess
level
viral
rna
myeloid
cell
result
mav
signal
inflammasom
activ
wnvinfect
doubl
knockout
dko
mice
succumb
later
time
point
compar
ifnar
mice
day
compar
day
despit
absenc
pathway
sens
control
wnv
infect
base
result
predict
absenc
mav
signal
wnvinfect
dko
mice
would
limit
cytokin
induct
despit
high
level
infect
viral
rna
gener
permiss
myeloid
cell
test
hypothesi
infect
ifnar
dko
wt
mice
wnv
harvest
serum
hour
analysi
viremia
reveal
higher
level
ifnar
ffuml
p
mav
ffuml
p
dko
ffuml
p
mice
compar
wt
ffuml
mice
fig
among
cell
isol
spleen
similar
percentag
cell
infect
wnv
ifnar
dko
mice
compar
wt
mice
fig
next
measur
cytokin
level
hour
wnv
infect
ifnar
dko
wt
mice
fig
tabl
serum
ifnar
mice
reveal
profil
elev
cytokin
level
microarray
analysi
spleen
wnvinfect
ifnar
dko
wt
mice
fig
corrobor
find
mrna
level
cytokin
associ
inflammasom
activ
eg
elev
spleen
ifnar
mice
compar
dko
wt
mice
defin
linkag
mav
cytokin
product
infect
bone
marrow
deriv
dc
bmdc
ifnar
dko
wt
mice
anticip
higher
level
wnv
infect
observ
ifnar
dko
cell
compar
wt
cell
fig
hour
detect
lower
amount
phosphoryl
subunit
ifnar
bmdc
fig
defici
mav
alon
howev
reduc
phosphoryl
substanti
indic
exist
mavsdepend
independ
yet
ifnardepend
pathway
activ
wnv
infect
absenc
mav
ifnar
notic
reduc
phosphoryl
well
lower
level
isg
mrna
fig
result
bmdc
consist
decreas
cytokin
produc
dko
compar
mice
elev
express
ifit
gene
wnvinfect
ifnar
mice
unexpect
even
though
ifit
gene
isg
express
induc
directli
ifnar
bmdc
increas
wnv
infect
result
enhanc
rna
pamp
gener
mav
signal
nuclear
transloc
induc
ifit
gene
independ
ifn
signal
pathway
observ
higher
level
serum
ifnar
mice
absent
dko
mice
fig
observ
suggest
prr
signal
mav
requir
inflammasom
activ
prior
studi
establish
key
nodlik
receptor
induc
restrict
wnv
infect
mice
test
whether
increas
level
observ
wnvinfect
ifnar
mice
due
excess
trigger
inflammasom
use
mab
block
ifnar
signal
wt
bmdc
mice
hour
wnv
infect
western
blot
analysi
reveal
reduc
amount
cleav
compar
treatedwt
bmdc
fig
despit
equival
level
viral
replic
fig
consist
blockad
type
ifn
signal
result
enhanc
mrna
express
cytokin
wt
bmdc
infect
wnv
fig
vivo
serum
cytokin
level
higher
wnvinfect
wt
mice
treat
compar
receiv
isotyp
control
mab
fig
howev
except
possibl
cytokin
level
wnvinfect
treat
wt
mice
similar
fig
data
shown
although
inflammasom
activ
gener
vasoact
cytokin
context
enhanc
wnv
replic
ifnarsign
defici
anim
contribut
viscer
organ
injuri
consist
inflammasom
assembl
signal
defici
anim
mice
treat
sustain
similar
gross
microscop
liver
renal
injuri
compar
wt
mice
treat
ifnar
mice
fig
data
shown
assess
whether
inflammatori
respons
contribut
multiorgan
injuri
lethal
neutral
activ
fig
administr
block
mab
inhibit
solubl
cell
surfaceassoci
form
one
day
prior
infect
increas
median
surviv
time
ifnar
day
p
cre
ifnar
ff
day
p
mice
support
hypothesi
multiorgan
failur
induc
cytokin
storm
contribut
diseas
ifnar
cre
ifnar
ff
mice
measur
viral
titer
serum
isotyp
control
mab
treat
mice
fig
viremia
hour
post
infect
differ
suggest
benefici
effect
therapi
due
effect
viral
replic
analysi
blood
chemistri
hour
infect
cre
ifnar
ff
ifnar
mice
follow
treatment
reveal
improv
ast
alt
glucos
level
differ
wnvinfect
ifnar
ff
control
mice
fig
tabl
cytokin
analysi
hour
infect
show
reduc
serum
level
cytokin
follow
mab
treatment
ifnar
cre
ifnar
ff
mice
tabl
although
reduc
level
observ
ifnar
mice
mab
treatment
five
cytokin
gmcsf
rant
decreas
cre
ifnar
ff
mice
alter
ifnar
mice
thu
blockad
reduc
induct
proinflammatori
cytokin
correl
cre
ifnar
ff
ifnar
anim
succumb
wnv
infect
less
rapidli
fig
human
infect
dengu
viru
close
relat
flaviviru
develop
vascular
leakag
sepsi
syndrom
evid
extens
complement
activ
plasma
tissu
prior
studi
also
establish
regul
express
complement
gene
myeloid
cell
hypothes
complement
activ
product
anaphylatoxin
eg
might
induc
contribut
diseas
pathogenesi
wnvinfect
ifnar
ff
mice
evalu
hypothesi
first
assess
mrna
level
individu
complement
compon
spleen
liver
wnvinfect
wt
mav
ifnar
mav
dko
mice
notabl
factor
b
fb
level
greater
wnvinfect
ifnar
mice
compar
genotyp
fig
suggest
express
key
complement
compon
regul
via
mavsdepend
pathway
next
examin
complement
activ
serum
assess
level
complement
protein
split
product
western
blot
elisa
hour
wnv
infect
level
fb
cleav
product
ba
higher
ifnar
ifnar
ff
mice
compar
wt
mice
fig
result
confirm
induct
key
complement
protein
activ
complement
cascad
vivo
contrast
fb
cleavag
product
decreas
absent
serum
wnvinfect
mav
ifnar
dko
mice
hour
fig
indic
rlr
signal
mav
requir
complement
induct
activ
consist
role
complement
contribut
pathogenesi
liver
injuri
hour
minim
wnvinfect
fb
mice
given
ifnarblock
mab
compar
similarlytr
wt
mice
analysi
blood
chemistri
wnv
infect
treat
fb
mice
reveal
normal
ast
alt
valu
compar
treat
control
mice
fig
even
though
viremia
cytokin
level
remain
elev
fig
f
liver
injuri
persist
mbla
dko
mice
indic
diseas
induc
primarili
alter
classic
lectin
pathway
complement
activ
glycemia
restor
normal
level
partial
phenotyp
also
observ
mice
delet
receptor
complement
anaphylatoxin
cytokin
liver
enzym
level
remain
elev
serum
glucos
level
normal
fig
comparison
treatment
ifnar
ff
mice
neutral
mab
reduc
liver
injuri
prevent
hypoglycemia
compar
anim
administ
isotyp
control
mab
fig
link
find
show
signal
complement
activ
contribut
wnvinduc
diseas
sepsi
assess
complement
activ
wnvinfect
ifnar
ff
mice
treat
block
mab
lower
level
factor
b
splitproduct
ba
observ
serum
plasma
mice
administ
block
compar
isotyp
control
mab
fig
experi
place
patholog
complement
activ
downstream
viral
infect
mav
signal
signal
indic
contribut
sepsislik
syndrom
although
contribut
type
ifn
signal
control
viral
infect
vivo
establish
import
specif
cell
subset
remain
less
well
understood
evalu
function
type
ifn
signal
myeloid
cell
vivo
wnv
infect
target
cell
prior
studi
indic
wnv
replic
preferenti
cell
strike
phenotyp
observ
wnv
infect
lysm
cre
ifnar
ff
mice
anim
succumb
similar
rate
kinet
compar
complet
gene
delet
ifnar
mice
contrast
delet
ifnar
express
b
cell
cre
ifnar
ff
show
phenotyp
wnv
infect
resembl
ifnar
ff
mice
viral
burden
sever
organ
cre
ifnar
ff
mice
markedli
elev
approach
seen
ifnar
mice
experi
reveal
domin
antivir
effect
vivo
type
ifn
signal
myeloid
cell
either
cell
patholog
analys
show
preferenti
wnv
infect
ifnar
myeloid
cell
result
cytokin
storm
associ
liver
kidney
damag
rapid
death
high
level
wnv
rna
ifnar
myeloid
cell
trigger
uncontrol
product
proinflammatori
cytokin
patholog
complement
induct
activ
togeth
caus
sepsislik
syndrom
phenotyp
occur
univers
wherea
ifnar
mice
succumb
infect
arthritogen
chikv
alphaviru
diseas
lethal
observ
lysm
cre
ifnar
ff
mice
phenotyp
wnv
infect
lysm
cre
ifnar
ff
mice
vari
observ
infect
mhv
mnov
mhv
studi
increas
vulner
observ
lysm
cre
ifnar
ff
mice
recapitul
seen
ifnar
mice
comparison
delet
ifnar
cell
result
subset
anim
die
occur
almost
week
later
mnov
studi
ifnardepend
respons
dc
limit
viral
infect
dispens
prevent
lethal
infect
mnovinfect
lysm
cre
ifnar
ff
anim
surviv
contrast
ifnar
mice
system
cytokin
level
measur
either
studi
relat
find
cell
typerestrict
delet
monocyt
granulocyt
lysm
cre
ff
dc
cre
ff
result
enhanc
lethal
listeria
monocytogen
infect
higher
level
cytokin
chemokin
observ
listeriainfect
lysm
cre
ff
mice
although
lower
infect
mice
analog
studi
listeriainfect
mice
lack
ifnar
express
also
sustain
liver
damag
thu
loss
ifnar
express
distinct
popul
cell
enhanc
pathogenesi
viral
bacteri
pathogen
although
level
mortal
cytokin
product
vari
ihc
flow
cytometr
analysi
tissu
blood
reveal
demonstr
fraction
infect
cell
cre
ifnar
ff
mice
belong
subset
remain
unclear
fraction
cell
target
could
reflect
differ
vulner
dc
subset
stochast
process
similar
phenomenon
observ
ex
vivo
wnv
infect
ifnar
bmdc
maximum
cell
infect
even
high
multipl
infect
comparison
chikv
target
myeloid
cell
infect
mice
thu
may
gain
replic
advantag
cre
ifnar
ff
lysm
cre
ifnar
ff
anim
prior
studi
ifnar
mice
virul
attenu
wnv
strain
reveal
enhanc
infect
lethal
suscept
phenotyp
relat
higher
level
wnv
replic
contribut
cytokin
assess
although
measur
high
viral
titer
serum
organ
brain
cre
ifnar
ff
ifnar
mice
ihc
reveal
less
viral
antigen
stain
brain
parenchyma
anticip
viral
titer
data
suggest
us
high
level
wnv
brain
homogen
could
due
infect
cell
intravascular
space
remov
despit
extens
perfus
andor
b
although
cre
ifnar
ff
lysm
cre
ifnar
ff
ifnar
mice
rapidli
succumb
wnv
might
due
infect
brain
inde
high
level
proinflammatori
cytokin
present
serum
lysm
cre
ifnar
ff
ifnar
mice
infect
ifnar
ff
mice
hour
vasoact
cytokin
affect
blood
vessel
permeabl
vascular
tone
could
limit
perfus
cre
ifnar
ff
ifnar
mice
result
consist
model
cytokinemedi
chang
vasculatur
limit
organ
perfus
result
high
titer
reflect
viral
burden
blood
rather
replic
within
parenchyma
tissu
cytokin
storm
reflect
excess
cytokin
product
occur
follow
infect
gramneg
bacteria
pathogen
influenza
virus
review
excess
cytokin
product
vascular
permeabl
chang
also
describ
flavivirus
context
sever
dengu
viru
infect
human
ifnsignalingdefici
mice
studi
cre
ifnar
ff
ifnar
mice
reveal
serum
level
twenti
differ
inflammatori
cytokin
elev
hour
wnv
inocul
loss
type
ifn
signal
myeloid
cell
affect
viral
tropism
result
dysregul
cytokin
respons
wnv
infect
combin
like
chang
vascular
resist
affect
perfus
result
compat
clinic
pictur
cytokin
storm
wnvinfect
lysm
cre
ifnar
ff
ifnar
mice
develop
mark
elev
serum
liver
enzym
profound
hypoglycemia
consist
hepatocellular
injuri
histopatholog
analysi
liver
cre
ifnar
ff
ifnar
mice
reveal
zonal
coagul
necrosi
apoptot
hepatocyt
similarli
spleen
ln
mark
chang
organ
architectur
cell
viabil
appar
viral
antigen
stain
present
lymphoid
organ
limit
liver
suggest
endorgan
damag
secondari
ischemia
andor
toxic
effect
cytokin
rather
direct
virusinduc
apoptosi
high
level
serum
wnvinfect
cre
ifnar
ff
lysm
cre
ifnar
ff
ifnar
mice
indic
signific
inflammasom
activ
wnv
activ
inflammasom
produc
matur
help
control
infect
brain
pathway
synerg
type
ifn
signal
inflammasom
activ
requir
two
signal
signal
induc
transcript
review
signal
promot
assembl
multiprotein
complex
activ
cleav
matur
form
high
amount
detect
serum
ifnar
lysm
cre
ifnar
ff
mice
indic
inflammasom
activ
wnv
infect
occur
independ
ifnar
signal
infect
myeloid
cell
lower
level
cytokin
serum
mav
dko
mice
establish
inflammasom
activ
follow
wnv
infect
occur
part
via
mavsdepend
pathway
recent
studi
context
bacteri
infect
suggest
role
ifnar
signal
inflammasom
activ
product
vasoc
cytokin
includ
wherea
context
francisella
tularensi
listeria
monocytogen
infect
ifnar
express
requir
inflammasom
activ
studi
mav
ifnar
signal
play
domin
role
anim
lack
ifnar
express
cell
enhanc
wnv
replic
produc
excess
viral
rna
pamp
recogn
cytosol
prr
rigi
sens
event
signal
mav
induc
proinflammatori
cytokin
inflammasomedepend
independ
eg
pathway
accordingli
combin
absenc
ifnar
mav
result
enhanc
infect
without
earli
cytokin
storm
dko
mice
succumb
infect
day
later
like
due
massiv
viru
infect
central
nervou
system
import
pathway
cytokin
induct
highlight
wnv
infect
studi
dko
mice
still
show
evid
liver
injuri
high
serum
ast
alt
overexuber
cytokin
product
k
pinto
diamond
unpublish
result
consist
hypothesi
proinflammatori
cytokin
contribut
wnvinduc
lethal
cre
ifnar
ff
ifnar
mice
administr
block
mab
prolong
surviv
affect
viral
replic
moreov
pretreat
mab
result
lower
system
cytokin
level
less
endorgan
tissu
injuri
hour
infect
somewhat
surprisingli
disrupt
inflammasom
activ
mice
affect
wnvinduc
liver
renal
injuri
ifnar
signal
block
analog
result
observ
ifnar
mice
treat
neutral
mab
k
pinto
diamond
unpublish
result
thu
even
though
mark
inflammasom
activ
context
cytokin
storm
cytokin
primarili
respons
sever
clinic
phenotyp
promot
sepsislik
syndrom
associ
enhanc
wnv
infect
myeloid
cell
although
high
level
serum
vasoact
effect
alter
endotheli
cell
barrier
integr
experi
suggest
altern
pathway
complement
activ
possibl
result
product
anaphylatoxin
contribut
phenotyp
liver
injuri
minim
wnvinfect
fb
mice
lack
type
ifn
signal
indic
tissu
damag
requir
activ
altern
complement
pathway
surviv
benefit
observ
wnvinfect
fb
mice
lack
type
ifn
signal
pinto
diamond
unpublish
result
like
rapid
spread
viru
central
nervou
system
due
absenc
protect
antivir
effect
complement
type
ifn
associ
wnv
infect
cre
ifnar
ff
ifnar
mice
observ
massiv
activ
complement
includ
accumul
fb
split
product
induct
fb
complement
protein
spleen
liver
occur
wnv
infect
mavsdepend
manner
inde
serum
mice
lack
mav
alon
mav
ifnar
fail
observ
accumul
fb
cleavag
product
wnv
infect
result
place
complement
induct
andor
activ
downstream
possibl
direct
action
myeloid
cell
andor
hepatocyt
propos
model
virusinduc
sepsislik
syndrom
fig
infect
myeloid
cell
result
excess
viral
rna
product
rigi
andor
recognit
mav
signal
activ
proinflammatori
cytokin
product
includ
complement
protein
induct
altern
pathway
activ
complement
anaphylatoxin
product
enhanc
infect
myeloid
cell
could
occur
experiment
blockad
genet
defici
ifnar
virusinduc
immun
evas
mechan
mani
human
virus
target
disen
key
compon
type
ifn
signal
cascad
recent
studi
bacteri
sepsi
model
also
suggest
key
role
fb
complement
peptid
mediat
vascular
leakag
hemodynam
instabl
pharmacolog
blockad
might
mitig
sepsislik
syndrom
viral
infect
includ
global
relev
flaviviru
dengu
viru
summari
data
establish
select
loss
ifnar
express
myeloid
cell
subset
result
unanticip
rapid
mortal
follow
wnv
infect
observ
ifnar
remov
cell
viral
model
still
restrict
ifnar
signal
pathway
cell
absenc
ifnar
signal
myeloid
cell
facilit
wnv
infect
caus
mavsdepend
dysregul
cytokin
respons
promot
induct
activ
altern
complement
pathway
result
tissu
injuri
differ
virus
antagon
ifnar
function
target
distinct
step
downstream
signal
pathway
includ
phosphoryl
review
model
infect
inflamm
may
relev
context
infect
given
find
target
anticytokin
andor
immunomodulatori
agent
may
possibl
therapeut
option
sepsi
induc
massiv
viral
infect
subset
myeloid
cell
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
protocol
approv
institut
anim
care
use
committe
washington
univers
school
medicin
assur
number
dissect
footpad
inject
perform
anesthesia
induc
maintain
ketamin
hydrochlorid
xylazin
effort
made
minim
suffer
wild
type
mice
purchas
commerci
jackson
laboratori
ifnar
mice
obtain
j
sprent
scripp
institut
san
diego
ca
backcross
ten
time
onto
background
cre
ifnar
ff
lysm
cre
ifnar
ff
mice
ifnar
ff
obtain
r
schreiber
st
loui
mo
u
kalink
hannov
germani
ifnar
ff
cre
lysm
cre
cre
mice
jackson
laboratori
backcross
use
speed
congen
analysi
judg
microsatellit
analysi
dko
mice
describ
previous
mice
report
previous
gift
r
wetsel
houston
tx
factor
dko
mice
report
previous
mice
hous
pathogenfre
mous
facil
washington
univers
school
medicin
univers
washington
experi
perform
accord
approv
feder
univers
regul
mice
weekold
inocul
subcutan
via
footpad
inject
plaqueform
unit
pfu
wnvni
pfu
chikvlr
wnvni
strain
wnvni
use
isol
new
york
passag
twice
aed
albopictu
cell
wnv
isol
tx
titer
standard
plaqu
assay
cell
work
stock
gener
previous
describ
chikv
strain
isol
infecti
clone
chikv
la
reunion
strain
chikvlr
gift
higg
manhattan
ks
passag
aed
albopictu
cell
bmdc
gener
previous
describ
fortyeight
hour
wnv
infect
blood
obtain
intracardiac
heart
punctur
spleen
recov
live
cell
stain
mab
specif
ifnar
biolegend
defin
cell
type
determin
ifnar
express
determin
leukocyt
infect
wnv
incub
mab
specif
leukocyt
surfac
marker
cell
fix
permeabil
fixat
permeabil
buffer
ebiosci
stain
combin
two
mous
antiwnv
specif
mab
wnv
wnv
mab
biolegend
sampl
process
lsrii
lsrfortessa
flow
cytomet
bd
bioscienc
result
data
analyz
use
flowjo
treestar
fortyeight
hour
wnv
infect
serum
obtain
intracardiac
heart
punctur
follow
intracardiac
perfus
ml
pb
organ
recoveri
organ
weigh
homogen
use
beadbeat
apparatu
titrat
focusform
assay
vero
cell
infect
cell
foci
stain
flaviviruscrossreact
chimer
mousehuman
mab
wnv
one
hour
wash
foci
detect
cell
incub
dilut
horseradish
peroxidas
hrp
conjug
goat
antihuman
igg
sigma
one
hour
stain
visual
addit
trueblu
detect
reagent
kpl
spot
analysi
biospot
counter
cellular
technolog
use
immunocaptur
softwar
eight
nineweek
old
ifnar
cre
ifnar
ff
ifnar
ff
mice
infect
wnv
fortyeight
hour
later
mice
perfus
sequenti
ml
pb
ml
pfa
pb
tissu
harvest
fix
pfa
pb
overnight
stain
hematoxylin
eosin
wnv
antigen
paraffinembed
tissu
section
perform
previous
describ
block
nonspecif
bind
site
section
incub
overnight
antiwnv
hyperimmun
rat
sera
primari
antibodi
detect
secondari
hrp
goat
antimous
rat
igg
molecular
probe
nuclei
counterstain
molecular
probe
tunel
stain
section
deparaffin
rehydr
heat
minut
incub
xylen
ethanol
ethanol
ethanol
distil
water
cell
permeabil
proteinas
k
roch
minut
dnase
sigma
treatment
minut
use
introduc
nick
dna
posit
control
situ
cell
death
detect
kit
tmr
red
roch
use
tdtmediat
dutp
nick
end
label
tunel
manufactur
protocol
follow
cell
counterstain
dapi
invitrogen
five
minut
slide
visual
use
axioscop
zeiss
microscop
imag
captur
axiocam
hrm
zeiss
axiovis
zeiss
softwar
use
control
experiment
imag
collect
process
use
instrument
set
wt
ifnar
lysm
cre
ifnar
ff
cre
ifnar
ff
ifnar
ff
mbla
mice
infect
wnv
specifi
time
blood
collect
serum
isol
bioplex
pro
assay
perform
accord
manufactur
protocol
biorad
cytokin
screen
includ
eotaxin
gcsf
gmcsf
kc
rant
ifnar
lysm
cre
ifnar
ff
cre
ifnar
ff
cre
ifnar
ff
mice
infect
wnv
specifi
time
blood
collect
intracardiac
heart
punctur
serum
isol
prior
analysi
sampl
treat
dilut
sigma
minut
inactiv
infecti
viral
particl
control
experi
confirm
impact
chemistri
result
data
shown
diagnost
laboratori
divis
compar
medicin
washington
univers
perform
blood
chemistri
analysi
obtain
mous
serum
whole
blood
clot
ice
minut
centrifug
min
fresh
serum
dilut
mix
equal
volum
sdspage
sampl
buffer
contain
sigma
minut
incub
room
temperatur
rt
sampl
heat
minut
sampl
subject
sdspage
use
trisglycin
run
buffer
transfer
nitrocellulos
membran
membran
block
overnight
nonfat
dri
milk
trisbor
salin
tb
buffer
primari
goat
antimous
dilut
mp
biomed
goat
antihuman
factor
b
dilut
complement
technolog
inc
antibodi
incub
membran
hour
rt
three
wash
tb
contain
tween
hrpconjug
rabbit
antigoat
igg
sigma
incub
h
three
wash
tbstween
membran
visual
use
supersign
west
kit
pierc
isotyp
control
mab
treat
cre
ifnar
ff
mice
infect
wnv
hour
infect
blood
collect
intracardiac
heart
punctur
edtaco
tube
plasma
isol
immedi
ad
microtit
plate
coat
overnight
captur
antibodi
bd
bioscienc
block
pb
bsa
sigma
one
hour
plate
incub
two
hour
room
temperatur
wash
detect
antibodi
bd
bioscienc
ad
two
hour
room
temperatur
wash
streptavidinhrp
invitrogen
ad
minut
room
temperatur
plate
develop
tetramethylbenzidin
substrat
dako
adjust
determin
subtract
valu
sampl
block
control
well
analyz
parallel
titer
repres
serum
dilut
yield
adjust
valu
equival
three
standard
deviat
background
assay
rna
isol
serum
use
rna
isol
kit
qiagen
measur
fluorogen
qrtpcr
use
primer
probe
sequenc
avail
upon
request
wnv
envelop
gene
use
onestep
rtpcr
master
mix
fast
realtim
pcr
system
appli
biosystem
antimous
mab
isotyp
control
mab
ratmous
chimer
monoclon
mab
gener
gift
sheali
janssen
r
spring
hous
pa
cre
ifnar
ff
ifnar
ff
mice
treat
singl
intraperiton
dose
mgkg
one
day
prior
infect
pfu
wnvni
isotyp
control
mab
treat
mice
monitor
surviv
serum
organ
harvest
hour
analysi
block
ifnar
signal
wt
specif
ko
mice
treat
singl
mg
mgkg
dose
isotyp
control
mab
one
day
prior
infect
describ
previous
block
function
cre
ifnar
ff
mice
treat
two
mg
mgkg
dose
isotyp
control
mab
day
rel
wnv
infect
describ
previous
express
oligonucleotid
array
perform
rna
isol
spleen
liver
tissu
strain
timematch
mock
infect
mice
wnvinfect
wt
dko
mice
rna
prepar
previous
describ
raw
data
load
customdesign
laboratori
inform
manag
system
lim
data
wareh
labkey
system
labkey
inc
seattl
wa
analyz
use
genedata
analyst
softwar
genedata
solut
silico
san
francisco
ca
tibco
spotfir
integrom
raw
microarray
data
deposit
ncbi
gene
express
omnibu
geo
seri
access
number
also
access
via
katz
laboratori
websit
wwwviromicswashingtonedu
accord
propos
minimum
inform
microarray
experi
miam
standard
student
ttest
perform
determin
gene
differ
express
level
wnv
infect
compar
mock
infect
four
mous
strain
wt
dko
bmdc
infect
wnv
moi
harvest
lyse
hour
later
wt
bmdc
treat
minut
prior
infect
maintain
throughout
assay
bmdc
lyse
ripa
buffer
mm
tri
mm
nacl
sodium
azid
sodium
deoxychol
triton
sd
ph
proteas
inhibitor
sigma
sampl
resolv
electrophoresi
sdspolyacrylamid
gel
follow
transfer
protein
membran
block
nonfat
dri
milk
probe
follow
panel
primari
antibodi
antiwnv
r
system
antimous
tubulin
sigma
antimous
gift
dr
g
sen
cleveland
oh
antimous
cell
signal
antimous
pro
cleav
form
abcam
cell
signal
cell
signal
data
analyz
use
prism
softwar
san
diego
ca
kaplanmei
surviv
curv
analyz
log
rank
test
differ
viral
burden
cytokin
level
blood
chemistri
analyz
mannwhitney
test
